These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18990330)

  • 21. Safety of fluvastatin in patients undergoing high-risk non-cardiac surgery.
    Voûte MT; Winkel TA; Poldermans D
    Expert Opin Drug Saf; 2010 Sep; 9(5):793-800. PubMed ID: 20557267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rab-small GTPases are involved in fluvastatin and pravastatin-induced vacuolation in rat skeletal myofibers.
    Sakamoto K; Honda T; Yokoya S; Waguri S; Kimura J
    FASEB J; 2007 Dec; 21(14):4087-94. PubMed ID: 17634390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin toxicity: a situation that mimics viral hepatitis.
    Cokça F; Ozkan S; Nergisoglu G; Memikoglu O; Azap A
    Int J Clin Pharmacol Ther; 2005 Nov; 43(11):543-5. PubMed ID: 16300170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-Induced Acute Liver Injury Within 12 Hours After Fluvastatin Therapy.
    Li L; Ma Y; Geng XB; Song YX; Tan Z; Shang XM; Zhao GY; Zhao BQ; Tian MR
    Am J Ther; 2016; 23(1):e318-20. PubMed ID: 24451297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muscular adverse effects of statins.
    Prescrire Int; 2003 Feb; 12(63):21. PubMed ID: 12602397
    [No Abstract]   [Full Text] [Related]  

  • 26. [A Woman Experienced Severe Thrombocytopenia When Treated With Fluvastatin].
    Potier A; Dony A; Crapsky A; Ferry O; Piney D; Dufay E
    Therapie; 2015; 70(6):541-4. PubMed ID: 26238127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of clopidogrel on the steady-state pharmacokinetics of fluvastatin.
    Ayalasomayajula SP; Vaidyanathan S; Kemp C; Prasad P; Balch A; Dole WP
    J Clin Pharmacol; 2007 May; 47(5):613-9. PubMed ID: 17442686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolerability of statins is not linked to CYP450 polymorphisms, but reduced CYP2D6 metabolism improves cholesteraemic response to simvastatin and fluvastatin.
    Zuccaro P; Mombelli G; Calabresi L; Baldassarre D; Palmi I; Sirtori CR
    Pharmacol Res; 2007 Apr; 55(4):310-7. PubMed ID: 17289397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
    Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential warfarin-fluvastatin interaction.
    Kline SS; Harrell CC
    Ann Pharmacother; 1997 Jun; 31(6):790. PubMed ID: 9184730
    [No Abstract]   [Full Text] [Related]  

  • 31. Fluvastatin for lowering cholesterol.
    Med Lett Drugs Ther; 1994 May; 36(923):45-6. PubMed ID: 8177137
    [No Abstract]   [Full Text] [Related]  

  • 32. Rhabdomyolysis secondary to hyponatraemia.
    Lara Aguayo P; de la Fuente Martos C; Morán Fernández E; Soriano Rodríguez F; Rojas Amezcua M; Aguilar Alonso E
    Nefrologia; 2011; 31(4):500-2. PubMed ID: 21738260
    [No Abstract]   [Full Text] [Related]  

  • 33. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
    Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
    Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Creatine kinase elevation caused by a combination of fluvastatin and telmisartan in a patient heterozygous for the CYP2C9*3 and ABCC2 -24C > T variants: a case report.
    Meyer zu Schwabedissen HE; Siegmund W; Kroemer HK; Rollnik JD
    BMC Res Notes; 2014 Oct; 7():688. PubMed ID: 25280537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluvastatin: a review of its use in lipid disorders.
    Langtry HD; Markham A
    Drugs; 1999 Apr; 57(4):583-606. PubMed ID: 10235694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluvastatin treatment is not associated with an increased incidence of cancer.
    Stein EA; Corsini A; Gimpelewicz CR; Bortolini M; Gil M
    Int J Clin Pract; 2006 Sep; 60(9):1028-34. PubMed ID: 16939542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of chronic treatment with statins and fenofibrate on rat skeletal muscle: a biochemical, histological and electrophysiological study.
    Pierno S; Didonna MP; Cippone V; De Luca A; Pisoni M; Frigeri A; Nicchia GP; Svelto M; Chiesa G; Sirtori C; Scanziani E; Rizzo C; De Vito D; Conte Camerino D
    Br J Pharmacol; 2006 Dec; 149(7):909-19. PubMed ID: 17031388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotype standardization for statin-induced myotoxicity.
    Alfirevic A; Neely D; Armitage J; Chinoy H; Cooper RG; Laaksonen R; Carr DF; Bloch KM; Fahy J; Hanson A; Yue QY; Wadelius M; Maitland-van Der Zee AH; Voora D; Psaty BM; Palmer CN; Pirmohamed M
    Clin Pharmacol Ther; 2014 Oct; 96(4):470-6. PubMed ID: 24897241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy and safety of fluvastatin extended-release tablets in Chinese patients with hyperlipidemia: a multi-center, randomized, double-blind, double dummy, active-controlled, parallel-group study].
    Zhao S; Wang F; Yang K; Hao Y; Li G; Yang M; Yang Z
    Zhonghua Nei Ke Za Zhi; 2014 Jun; 53(6):455-9. PubMed ID: 25146513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Myopathy secondary to the treatment with inhibitors of HMG-CoA reductase].
    Fuentes I; Aguilera C
    Med Clin (Barc); 1998 Nov; 111(18):700. PubMed ID: 9887435
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.